|
|
pigmentation
|
GO:0043473 |
71 |
1.000
|
|
|
|
pigment granule localization
|
GO:0051875 |
13 |
0.999
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.998
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.998
|
|
|
|
cellular pigmentation
|
GO:0033059 |
20 |
0.995
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
27 |
0.993
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.992
|
|
|
|
melanosome localization
|
GO:0032400 |
12 |
0.991
|
|
|
|
establishment of melanosome localization
|
GO:0032401 |
11 |
0.979
|
|
|
|
melanosome transport
|
GO:0032402 |
11 |
0.962
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.954
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
26 |
0.951
|
|
|
|
secondary metabolite biosynthetic process
|
GO:0044550 |
11 |
0.936
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.920
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.902
|
|
|
|
melanosome organization
|
GO:0032438 |
8 |
0.842
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.792
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.760
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.755
|
|
|
|
pigment granule transport
|
GO:0051904 |
12 |
0.691
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.641
|
|
|
|
pigment granule organization
|
GO:0048753 |
9 |
0.621
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.592
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.566
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.559
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.559
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.547
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.530
|
|
|
|
melanin biosynthetic process
|
GO:0042438 |
10 |
0.511
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.507
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.480
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.469
|
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.456
|
|
|
|
establishment of pigment granule localization
|
GO:0051905 |
12 |
0.451
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.381
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.374
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.365
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.344
|
|
|
|
natural killer cell activation involved in immune response
|
GO:0002323 |
10 |
0.311
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.297
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.282
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.278
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.273
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.264
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.264
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.262
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.258
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.251
|
Mouse |
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.240
|
Mouse |
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.237
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.237
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.233
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.233
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.229
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.225
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.219
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.214
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.210
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.205
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.202
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.195
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.193
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.187
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.185
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.184
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.179
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.174
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.173
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.168
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.168
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.168
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.167
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.167
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.167
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.166
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.158
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.158
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.155
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.150
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.150
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.147
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.147
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.143
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.142
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.140
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.139
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.139
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.138
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.137
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.135
|
|
|
|
corticosterone secretion
|
GO:0035934 |
3 |
0.132
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.131
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.128
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.128
|
|
|
|
secretory granule organization
|
GO:0033363 |
20 |
0.124
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.124
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.121
|
|
|
|
branching involved in prostate gland morphogenesis
|
GO:0060442 |
15 |
0.121
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.119
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.118
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.116
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.116
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.115
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.114
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.114
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.113
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.113
|
|
|
|
short chain fatty acid metabolic process
|
GO:0046459 |
6 |
0.110
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.110
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.110
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.108
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.106
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.106
|
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.105
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.105
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.104
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.103
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.102
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.101
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.101
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.100
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.098
|
|
|
|
eye pigmentation
|
GO:0048069 |
3 |
0.097
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.097
|
|
|
|
regulation of corticosterone secretion
|
GO:2000852 |
2 |
0.097
|
|
|
|
regulation of pigment cell differentiation
|
GO:0050932 |
7 |
0.094
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.094
|
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.093
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.092
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.092
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.091
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.091
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.090
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.090
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.088
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.087
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.087
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.087
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.086
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.085
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.085
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.084
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.084
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.083
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.083
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.083
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.083
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.081
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.079
|
|
|
|
secretion of lysosomal enzymes
|
GO:0033299 |
6 |
0.079
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.078
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.077
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.077
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.077
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.076
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.075
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.075
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.074
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.073
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.073
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.072
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.071
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.071
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.071
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.070
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.069
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.069
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.069
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.069
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.068
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.068
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.067
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.067
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.067
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.066
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.066
|
|
|
|
glucocorticoid secretion
|
GO:0035933 |
6 |
0.065
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.065
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.064
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.064
|
|
|
|
renal vesicle morphogenesis
|
GO:0072077 |
15 |
0.064
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.063
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.063
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.063
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.062
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.062
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.062
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.061
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.061
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.060
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.060
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.059
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.059
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.059
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.058
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.058
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.058
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.058
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.058
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.057
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.057
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.057
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.056
|
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.056
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.056
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.056
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.055
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.055
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.055
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.055
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.055
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.055
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.054
|
|
|
|
catecholamine biosynthetic process
|
GO:0042423 |
11 |
0.054
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.053
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.053
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.053
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.053
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.052
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.052
|
|
|
|
melanin metabolic process
|
GO:0006582 |
12 |
0.052
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.052
|
|
|
|
t cell differentiation involved in immune response
|
GO:0002292 |
30 |
0.052
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.051
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.051
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.050
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.050
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.050
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.050
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.050
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.050
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.050
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.050
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.049
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.048
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.048
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.048
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.048
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.048
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.048
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.047
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.046
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.046
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.046
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.046
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.045
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.045
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.045
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.045
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.045
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.045
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.045
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.045
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.044
|
|
|
|
positive regulation of natural killer cell activation
|
GO:0032816 |
15 |
0.044
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.044
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.044
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.043
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.043
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.043
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.043
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.043
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.042
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.042
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.042
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.042
|
|
|
|
neuroblast division
|
GO:0055057 |
10 |
0.041
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.041
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.041
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.041
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.041
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.041
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.041
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.041
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.041
|
|
|
|
positive regulation of glucose metabolic process
|
GO:0010907 |
21 |
0.040
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.040
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.040
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.040
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.040
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.039
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.039
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.039
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.039
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.039
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.039
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.038
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.038
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.038
|
|
|
|
regulation of developmental pigmentation
|
GO:0048070 |
14 |
0.038
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.037
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.037
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.037
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.037
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.037
|
|
|
|
regulation of glucocorticoid secretion
|
GO:2000849 |
5 |
0.037
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.037
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.037
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.037
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.037
|
|
|
|
renal vesicle formation
|
GO:0072033 |
8 |
0.037
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.036
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.036
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.036
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.036
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.036
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.036
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.036
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.036
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.036
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.036
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.035
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.035
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.035
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.034
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.034
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.034
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.034
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.034
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.034
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.034
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.034
|
|
|
|
stem cell division
|
GO:0017145 |
30 |
0.034
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.033
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.033
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.033
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.033
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.033
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.033
|
|
|
|
phagosome maturation
|
GO:0090382 |
4 |
0.033
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.033
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.032
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.032
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.032
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.032
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.032
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.032
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.032
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.032
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.032
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.032
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.032
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.032
|
|
|
|
enteroendocrine cell differentiation
|
GO:0035883 |
16 |
0.032
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.032
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.032
|
|
|
|
regulation of corticosteroid hormone secretion
|
GO:2000846 |
5 |
0.032
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.031
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.031
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.031
|
|
|
|
aromatic amino acid family metabolic process
|
GO:0009072 |
9 |
0.031
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.031
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.031
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.031
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.031
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.031
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.031
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.031
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.031
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.031
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.030
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.030
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.030
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.030
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.030
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.030
|
|
|
|
regulation of glycogen metabolic process
|
GO:0070873 |
13 |
0.030
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.030
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.030
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.030
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.030
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.029
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.029
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.029
|
|
|
|
response to ethanol
|
GO:0045471 |
18 |
0.029
|
|
|
|
hair cycle phase
|
GO:0044851 |
16 |
0.029
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.029
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.029
|
|
|
|
mast cell proliferation
|
GO:0070662 |
4 |
0.029
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.029
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.029
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.029
|
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.028
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.028
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.028
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.028
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.028
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.028
|
|
|
|
sensory perception of taste
|
GO:0050909 |
18 |
0.027
|
|
|
|
regulation of myoblast proliferation
|
GO:2000291 |
8 |
0.027
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.027
|
|
|
|
regulation of cerebellar granule cell precursor proliferation
|
GO:0021936 |
12 |
0.027
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.027
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.027
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.027
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.027
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.027
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.026
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.026
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.026
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.026
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.026
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.026
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.026
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.026
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.026
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.026
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.026
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.026
|
|
|
|
anion homeostasis
|
GO:0055081 |
16 |
0.025
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.025
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.025
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.025
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.025
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.025
|
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.025
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.025
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.025
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.025
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.025
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.024
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.024
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.024
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.024
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.024
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.024
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.024
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.024
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.024
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.024
|
|
|
|
face development
|
GO:0060324 |
38 |
0.024
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.024
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.024
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.024
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.024
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.024
|
|
|
|
negative regulation of t cell differentiation
|
GO:0045581 |
23 |
0.024
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.023
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.023
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.023
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.023
|
|
|
|
positive regulation of focal adhesion assembly
|
GO:0051894 |
5 |
0.023
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.023
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
|
forebrain neuroblast division
|
GO:0021873 |
9 |
0.023
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.023
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.023
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.023
|
|
|
|
tyrosine metabolic process
|
GO:0006570 |
4 |
0.023
|
|
|
|
chorio allantoic fusion
|
GO:0060710 |
8 |
0.023
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.023
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.022
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.022
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.022
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.022
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.022
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.022
|
|
|
|
regulation of glutamate secretion
|
GO:0014048 |
3 |
0.022
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.022
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.022
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.022
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.022
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.022
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.022
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.022
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.022
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.021
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.021
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.021
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.021
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.021
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.021
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.021
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.021
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.021
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.021
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.021
|
|
|
|
glycogen biosynthetic process
|
GO:0005978 |
14 |
0.021
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.021
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.021
|
|
